Articles and Videos
InMed CEO says ‘tremendous potential’ for its cannabinoid-based therapy to treat glaucoma
InMed Pharmaceuticals Inc (CSE:IN) (OTCMKTS:IMLFF) CEO Eric Adams sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. In this interview,...
Source: Proactive Investors
Biosynthesis of Cannabinoids – Producing Cannabinoids Without the Plant!
A biosynthesis platform technology Cannabinoids are closely related compounds that are the active constituents of the cannabis plant. While there are over 100 different cannabinoids, the...